Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.16
STE's Cash to Debt is ranked lower than
87% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.82 vs. STE: 0.16 )
Ranked among companies with meaningful Cash to Debt only.
STE' s Cash to Debt Range Over the Past 10 Years
Min: 0.04  Med: 0.3 Max: 56.7
Current: 0.16
0.04
56.7
Equity to Asset 0.57
STE's Equity to Asset is ranked lower than
54% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. STE: 0.57 )
Ranked among companies with meaningful Equity to Asset only.
STE' s Equity to Asset Range Over the Past 10 Years
Min: 0.45  Med: 0.57 Max: 0.66
Current: 0.57
0.45
0.66
Interest Coverage 5.08
STE's Interest Coverage is ranked lower than
82% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 40.78 vs. STE: 5.08 )
Ranked among companies with meaningful Interest Coverage only.
STE' s Interest Coverage Range Over the Past 10 Years
Min: 4.99  Med: 15.46 Max: 20.66
Current: 5.08
4.99
20.66
F-Score: 4
Z-Score: 2.61
M-Score: -1.92
WACC vs ROIC
10.17%
5.11%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 9.94
STE's Operating margin (%) is ranked higher than
64% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.82 vs. STE: 9.94 )
Ranked among companies with meaningful Operating margin (%) only.
STE' s Operating margin (%) Range Over the Past 10 Years
Min: 7.06  Med: 12.52 Max: 16.2
Current: 9.94
7.06
16.2
Net-margin (%) 5.53
STE's Net-margin (%) is ranked higher than
58% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.54 vs. STE: 5.53 )
Ranked among companies with meaningful Net-margin (%) only.
STE' s Net-margin (%) Range Over the Past 10 Years
Min: 4.25  Med: 7.64 Max: 10.65
Current: 5.53
4.25
10.65
ROE (%) 6.01
STE's ROE (%) is ranked higher than
54% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.89 vs. STE: 6.01 )
Ranked among companies with meaningful ROE (%) only.
STE' s ROE (%) Range Over the Past 10 Years
Min: 5.41  Med: 12.93 Max: 18.11
Current: 6.01
5.41
18.11
ROA (%) 3.29
STE's ROA (%) is ranked higher than
58% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.66 vs. STE: 3.29 )
Ranked among companies with meaningful ROA (%) only.
STE' s ROA (%) Range Over the Past 10 Years
Min: 2.98  Med: 6.98 Max: 10.46
Current: 3.29
2.98
10.46
ROC (Joel Greenblatt) (%) 21.09
STE's ROC (Joel Greenblatt) (%) is ranked higher than
66% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.45 vs. STE: 21.09 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
STE' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 16.35  Med: 29.93 Max: 38.9
Current: 21.09
16.35
38.9
Revenue Growth (3Y)(%) 7.20
STE's Revenue Growth (3Y)(%) is ranked higher than
60% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. STE: 7.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
STE' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0.6  Med: 7.2 Max: 10.6
Current: 7.2
0.6
10.6
EBITDA Growth (3Y)(%) -1.70
STE's EBITDA Growth (3Y)(%) is ranked lower than
71% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.90 vs. STE: -1.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
STE' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -18.1  Med: 6.7 Max: 68.4
Current: -1.7
-18.1
68.4
EPS Growth (3Y)(%) -16.90
STE's EPS Growth (3Y)(%) is ranked lower than
75% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.80 vs. STE: -16.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
STE' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -72.2  Med: 3.9 Max: 293.6
Current: -16.9
-72.2
293.6
» STE's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-10-30)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q3 2015

STE Guru Trades in Q3 2015

Steven Cohen 215,800 sh (New)
Ray Dalio 6,505 sh (New)
RS Investment Management 1,429,523 sh (+33.71%)
Jim Simons 244,600 sh (+13.93%)
Ken Fisher 1,620,543 sh (+0.45%)
Jeremy Grantham 7,900 sh (unchged)
Mario Gabelli 110,000 sh (-0.90%)
Chuck Royce 610,441 sh (-23.87%)
Paul Tudor Jones 12,600 sh (-42.43%)
Joel Greenblatt 61,303 sh (-87.64%)
» More
Q4 2015

STE Guru Trades in Q4 2015

Paul Singer 366,180 sh (New)
Keeley Asset Management Corp 3,125 sh (New)
Jeremy Grantham 78,892 sh (+898.63%)
Paul Tudor Jones 18,300 sh (+45.24%)
Chuck Royce 610,441 sh (unchged)
Mario Gabelli Sold Out
Ray Dalio Sold Out
Joel Greenblatt Sold Out
Ken Fisher 1,616,613 sh (-0.24%)
RS Investment Management 1,416,008 sh (-0.95%)
Steven Cohen 151,900 sh (-29.61%)
Jim Simons 146,100 sh (-40.27%)
» More
Q1 2016

STE Guru Trades in Q1 2016

Mario Gabelli 103,000 sh (New)
Keeley Asset Management Corp 3,125 sh (unchged)
Jim Simons Sold Out
Paul Singer Sold Out
Steven Cohen Sold Out
Ken Fisher 1,613,920 sh (-0.17%)
Chuck Royce 572,383 sh (-6.23%)
Jeremy Grantham 71,992 sh (-8.75%)
RS Investment Management 1,182,867 sh (-16.46%)
Paul Tudor Jones 7,300 sh (-60.11%)
» More
Q2 2016

STE Guru Trades in Q2 2016

Jim Simons 637,000 sh (New)
Paul Tudor Jones 8,400 sh (+15.07%)
Ken Fisher 1,622,504 sh (+0.53%)
Mario Gabelli 103,000 sh (unchged)
Jeremy Grantham 71,418 sh (-0.80%)
Keeley Asset Management Corp 2,943 sh (-5.82%)
Chuck Royce 368,883 sh (-35.55%)
RS Investment Management 358,849 sh (-69.66%)
» More
» Details

Insider Trades

Latest Guru Trades with STE

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:OTCPK:SAUHY, NYSE:WST, NAS:SIRO, OTCPK:GNGBF, NYSE:HRC, OTCPK:AHICF, NYSE:COO, NYSE:CMN, OTCPK:ANSLF, OTCPK:GRRMF, NAS:PODD, NYSE:RMD, NAS:ICUI, NYSE:HAE, NYSE:HYH, NAS:NXTM, OTCPK:TOPCF, NAS:HOLX, NYSE:MTD, NAS:MMSI » details
Traded in other countries:1S4.Germany,
STERIS PLC is a provider of infection prevention and other procedural products and services, focused on healthcare, pharmaceutical and research.

STERIS PLC formerly Steris Corp was founded in October 9, 2014. The Company is a provider of infection prevention and other procedural products and services, focused on healthcare, pharmaceutical and research. It offers a mix of capital equipment products, such as sterilizers and surgical tables, and connectivity solutions such as operating room ('OR') integration; consumable products, such as detergents and skin care products, gastrointestinal ('GI') endoscopy accessories, and other products; services, including equipment installation and maintenance; and microbial reduction of medical devices, instrument and scope repair solutions, and laboratory testing services. The Company operates in four reportable business segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. Healthcare Products segment offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance and installation services, as well as consumables. Healthcare Specialty Services segment provides a range of specialty services for healthcare providers including hospital sterilization services, instrument and scope repairs, and linen management. Life Sciences segment offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities. Applied Sterilization Technologies segment offers contract sterilization and laboratory services for medical device and pharmaceutical Customers and others. The Company is subject to various laws and governmental regulations concerning environmental matters and employee safety and health in the United States and in other countries.

Ratios

vs
industry
vs
history
P/E(ttm) 41.04
STE's P/E(ttm) is ranked lower than
73% of the 117 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.67 vs. STE: 41.04 )
Ranked among companies with meaningful P/E(ttm) only.
STE' s P/E(ttm) Range Over the Past 10 Years
Min: 11.08  Med: 22 Max: 54.83
Current: 41.04
11.08
54.83
Forward P/E 26.53
STE's Forward P/E is ranked lower than
69% of the 39 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.99 vs. STE: 26.53 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 41.04
STE's PE(NRI) is ranked lower than
74% of the 117 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.65 vs. STE: 41.04 )
Ranked among companies with meaningful PE(NRI) only.
STE' s PE(NRI) Range Over the Past 10 Years
Min: 11.08  Med: 22.25 Max: 54.83
Current: 41.04
11.08
54.83
Price/Owner Earnings (ttm) 30.79
STE's Price/Owner Earnings (ttm) is ranked lower than
56% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.13 vs. STE: 30.79 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
STE' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 8.79  Med: 19.43 Max: 60.59
Current: 30.79
8.79
60.59
P/B 2.00
STE's P/B is ranked higher than
68% of the 186 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.20 vs. STE: 2.00 )
Ranked among companies with meaningful P/B only.
STE' s P/B Range Over the Past 10 Years
Min: 1.68  Med: 2.38 Max: 4.19
Current: 2
1.68
4.19
P/S 2.14
STE's P/S is ranked higher than
59% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.97 vs. STE: 2.14 )
Ranked among companies with meaningful P/S only.
STE' s P/S Range Over the Past 10 Years
Min: 0.95  Med: 1.55 Max: 2.41
Current: 2.14
0.95
2.41
PFCF 32.81
STE's PFCF is ranked lower than
60% of the 82 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.76 vs. STE: 32.81 )
Ranked among companies with meaningful PFCF only.
STE' s PFCF Range Over the Past 10 Years
Min: 8.77  Med: 23.28 Max: 113.68
Current: 32.81
8.77
113.68
POCF 17.66
STE's POCF is ranked lower than
52% of the 101 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.50 vs. STE: 17.66 )
Ranked among companies with meaningful POCF only.
STE' s POCF Range Over the Past 10 Years
Min: 7.12  Med: 13.53 Max: 25.64
Current: 17.66
7.12
25.64
EV-to-EBIT 30.29
STE's EV-to-EBIT is ranked lower than
72% of the 117 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.24 vs. STE: 30.29 )
Ranked among companies with meaningful EV-to-EBIT only.
STE' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.2  Med: 14 Max: 40.2
Current: 30.29
7.2
40.2
EV-to-EBITDA 17.65
STE's EV-to-EBITDA is ranked lower than
52% of the 132 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.27 vs. STE: 17.65 )
Ranked among companies with meaningful EV-to-EBITDA only.
STE' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.4  Med: 9.7 Max: 24.9
Current: 17.65
5.4
24.9
PEG 3.34
STE's PEG is ranked lower than
57% of the 61 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.06 vs. STE: 3.34 )
Ranked among companies with meaningful PEG only.
STE' s PEG Range Over the Past 10 Years
Min: 0.61  Med: 2.53 Max: 15.61
Current: 3.34
0.61
15.61
Shiller P/E 35.42
STE's Shiller P/E is ranked higher than
60% of the 48 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 43.14 vs. STE: 35.42 )
Ranked among companies with meaningful Shiller P/E only.
STE' s Shiller P/E Range Over the Past 10 Years
Min: 17.91  Med: 26.19 Max: 41.19
Current: 35.42
17.91
41.19
Current Ratio 2.63
STE's Current Ratio is ranked higher than
53% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.49 vs. STE: 2.63 )
Ranked among companies with meaningful Current Ratio only.
STE' s Current Ratio Range Over the Past 10 Years
Min: 1.71  Med: 2.38 Max: 3.57
Current: 2.63
1.71
3.57
Quick Ratio 2.05
STE's Quick Ratio is ranked higher than
61% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.66 vs. STE: 2.05 )
Ranked among companies with meaningful Quick Ratio only.
STE' s Quick Ratio Range Over the Past 10 Years
Min: 1.26  Med: 1.7 Max: 2.84
Current: 2.05
1.26
2.84
Days Inventory 48.07
STE's Days Inventory is ranked higher than
89% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 124.07 vs. STE: 48.07 )
Ranked among companies with meaningful Days Inventory only.
STE' s Days Inventory Range Over the Past 10 Years
Min: 48.04  Med: 64.1 Max: 70.76
Current: 48.07
48.04
70.76
Days Sales Outstanding 65.87
STE's Days Sales Outstanding is ranked lower than
59% of the 164 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 60.82 vs. STE: 65.87 )
Ranked among companies with meaningful Days Sales Outstanding only.
STE' s Days Sales Outstanding Range Over the Past 10 Years
Min: 62.38  Med: 71.33 Max: 82.3
Current: 65.87
62.38
82.3
Days Payable 30.28
STE's Days Payable is ranked lower than
78% of the 158 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 47.28 vs. STE: 30.28 )
Ranked among companies with meaningful Days Payable only.
STE' s Days Payable Range Over the Past 10 Years
Min: 30.28  Med: 36.71 Max: 43.62
Current: 30.28
30.28
43.62

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.47
STE's Dividend Yield is ranked higher than
56% of the 149 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.39 vs. STE: 1.47 )
Ranked among companies with meaningful Dividend Yield only.
STE' s Dividend Yield Range Over the Past 10 Years
Min: 0.31  Med: 1.38 Max: 2.34
Current: 1.47
0.31
2.34
Dividend Payout 0.58
STE's Dividend Payout is ranked lower than
64% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.33 vs. STE: 0.58 )
Ranked among companies with meaningful Dividend Payout only.
STE' s Dividend Payout Range Over the Past 10 Years
Min: 0.11  Med: 0.26 Max: 1.79
Current: 0.58
0.11
1.79
Dividend Growth (3y) 9.80
STE's Dividend Growth (3y) is ranked lower than
56% of the 66 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.90 vs. STE: 9.80 )
Ranked among companies with meaningful Dividend Growth (3y) only.
STE' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 34.7
Current: 9.8
0
34.7
Forward Dividend Yield 1.60
STE's Forward Dividend Yield is ranked higher than
56% of the 135 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. STE: 1.60 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 2.54
STE's Yield on cost (5-Year) is ranked higher than
68% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.97 vs. STE: 2.54 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
STE' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.54  Med: 2.39 Max: 4.05
Current: 2.54
0.54
4.05
3-Year Average Share Buyback Ratio -13.50
STE's 3-Year Average Share Buyback Ratio is ranked lower than
76% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.80 vs. STE: -13.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
STE' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -13.5  Med: 0.1 Max: 5.2
Current: -13.5
-13.5
5.2

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.62
STE's Price/Projected FCF is ranked higher than
61% of the 89 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.94 vs. STE: 1.62 )
Ranked among companies with meaningful Price/Projected FCF only.
STE' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.83  Med: 1.44 Max: 14.78
Current: 1.62
0.83
14.78
Price/DCF (Earnings Based) 3.31
STE's Price/DCF (Earnings Based) is ranked lower than
76% of the 17 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. STE: 3.31 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.37
STE's Price/Median PS Value is ranked lower than
62% of the 173 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.18 vs. STE: 1.37 )
Ranked among companies with meaningful Price/Median PS Value only.
STE' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.54  Med: 1.04 Max: 1.95
Current: 1.37
0.54
1.95
Earnings Yield (Greenblatt) (%) 3.28
STE's Earnings Yield (Greenblatt) (%) is ranked higher than
57% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.90 vs. STE: 3.28 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
STE' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2.5  Med: 7.15 Max: 13.8
Current: 3.28
2.5
13.8
Forward Rate of Return (Yacktman) (%) 5.72
STE's Forward Rate of Return (Yacktman) (%) is ranked lower than
64% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.18 vs. STE: 5.72 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
STE' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 5.6  Med: 12.9 Max: 36.2
Current: 5.72
5.6
36.2

More Statistics

Revenue (TTM) (Mil) $2,437
EPS (TTM) $ 1.72
Beta1.33
Short Percentage of Float2.78%
52-Week Range $61.09 - 78.77
Shares Outstanding (Mil)86.15

Analyst Estimate

Mar17 Mar18
Revenue (Mil $) 2,747 2,911
EPS ($) 2.65 4.16
EPS w/o NRI ($) 2.65 4.16
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for NYSE:STE

Headlines

Articles On GuruFocus.com
Mutual Funds Make Trades in 3 Continents Jul 01 2016 
16 Best Dividend Paying Healthcare Stocks Sep 03 2012 
Supply Your Portfolio with Healthy Growth from Medical Suppliers May 25 2012 
STERIS Corp. Reports Operating Results (10-Q) Feb 09 2011 
STERIS Corp. Reports Operating Results (10-Q) Nov 09 2010 
STERIS Corp. (STE) President & CEO Walter M Jr Rosebrough sells 11,600 Shares Oct 01 2010 
STERIS Corp. (STE) SVP & CFO Michael J Tokich sells 9,000 Shares Apr 09 2010 
STERIS Corp. Reports Operating Results (10-Q) Feb 09 2010 
Robert Olstein on Hedge Fund regulations. Recent Olstein buys. Jan 15 2010 
STERIS Corp. Reports Operating Results (10-Q) Nov 03 2009 

More From Other Websites
Huge Jumps In Hedge Fund Popularity For These 5 Healthcare Stocks Aug 26 2016
[$$] 3 Small-Cap Stocks Worth Buying Now Aug 26 2016
ETF’s with exposure to STERIS Plc : August 26, 2016 Aug 26 2016
STERIS Plc breached its 50 day moving average in a Bearish Manner : STE-US : August 25, 2016 Aug 25 2016
STERIS Hit by Currency Fluctuations, Customer Consolidation Aug 19 2016
STERIS PLC Financials Aug 18 2016
STERIS (STE) Beats on Q1 Earnings, Lowers FY17 Sales View Aug 11 2016
STERIS Plc :STE-US: Earnings Analysis: Q1, 2017 By the Numbers : August 10, 2016 Aug 10 2016
Edited Transcript of STE earnings conference call or presentation 9-Aug-16 2:00pm GMT Aug 09 2016
STERIS plc Earnings Call scheduled for 10:00 am ET today Aug 09 2016
Q1 2017 STERIS plc Earnings Release - Before Market Open Aug 09 2016
Steris tops 1Q profit forecasts Aug 09 2016
Steris tops 1Q profit forecasts Aug 09 2016
STERIS plc Announces Financial Results for Fiscal 2017 First Quarter Aug 09 2016
STERIS PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 09 2016
STERIS plc Announces Financial Results for Fiscal 2017 First Quarter Aug 09 2016
ETF’s with exposure to STERIS Plc : August 8, 2016 Aug 08 2016
Medical Product Stocks' Earnings on Aug 9: PEN, STE & More Aug 08 2016
STERIS PLC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Aug 03 2016
STERIS Plc :STE-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016 Jul 26 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)